Search General Info
Search Education
Search Partnering Companies

J. Joseph Kim, PhD

United States
Dr. J. Joseph Kim has served as president and chief executive of INOVIO since 2009, leading the company’s transformation into a successful late-stage biotech focused on developing breakthrough DNA medicines that treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases.

An immunologist by training, Dr. Kim has a deep understanding of the complexities of medical science’s greatest unsolved challenges. He is committed to improving the lives of patients, and this passion permeates the company.

Dr. Kim has published more than 100 peer-reviewed scientific papers, holds numerous patents, and sits on several scientific journal editorial boards. Most recently, he was recognized as a Young Global Leader by the World Economic Forum and a Health Innovators Fellow at The Aspen Institute. He previously co-founded VGX Pharmaceuticals, an immunotherapeutic company that he led for nine years before merging VGX with INOVIO Biomedical in 2009 to form INOVIO.

Dr. Kim earned two B.S. degrees in Chemical Engineering and Economics from the Massachusetts Institute of Technology, a Ph.D. in Immunology and an M.S. in Engineering from the University Pennsylvania, and an M.B.A. in Finance from the Wharton School.
Speaking In
9:00 AM - 9:55 AM (PDT)
Thursday, June 11
The pace of a medical crisis (not only a pandemic like coronavirus, but a more focal but lethal…